.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Fuji
Mallinckrodt
US Department of Justice
Argus Health
Baxter
Julphar
Harvard Business School
Dow
Medtronic

Generated: July 24, 2017

DrugPatentWatch Database Preview

TORNALATE Drug Profile

« Back to Dashboard

What is the patent landscape for Tornalate, and when can generic versions of Tornalate launch?

Tornalate is a drug marketed by Sanofi Aventis Us and is included in two NDAs.

The generic ingredient in TORNALATE is bitolterol mesylate. Additional details are available on the bitolterol mesylate profile page.

Summary for Tradename: TORNALATE

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list9
Patent Applications: see list1,027
Drug Prices:see details
DailyMed Link:TORNALATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
TORNALATE
bitolterol mesylate
SOLUTION;INHALATION019548-001Feb 19, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
TORNALATE
bitolterol mesylate
AEROSOL, METERED;INHALATION018770-001Dec 28, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TORNALATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us
TORNALATE
bitolterol mesylate
SOLUTION;INHALATION019548-001Feb 19, 1992► Subscribe► Subscribe
Sanofi Aventis Us
TORNALATE
bitolterol mesylate
AEROSOL, METERED;INHALATION018770-001Dec 28, 1984► Subscribe► Subscribe
Sanofi Aventis Us
TORNALATE
bitolterol mesylate
AEROSOL, METERED;INHALATION018770-001Dec 28, 1984► Subscribe► Subscribe
Sanofi Aventis Us
TORNALATE
bitolterol mesylate
SOLUTION;INHALATION019548-001Feb 19, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Citi
Mallinckrodt
Deloitte
Covington
Harvard Business School
Express Scripts
Queensland Health
US Department of Justice
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot